Scoliosis
Conditions
Interventions
Experimental group:The incision infiltration solution consisted of 0.2% ropivacaine combined with 0.025% dexamethasone.
Control group:The incision infiltration solution consisted of 0.2% ropivacaine
Sponsors
Beijing Children's Hospital, National Center for Children's Health, Capital Medical University
Eligibility
Sex/Gender
All
Age
4 Years to 18 Years
Inclusion criteria
Inclusion criteria: 1. Hospitalized children aged 4-18 years, with ASA grades I-II; 2. Children scheduled for spinal curvature correction surgery and receiving intravenous patient-controlled analgesia with sufentanil after the surgery; 3. Capable of self-reporting or having it relayed by their family members, and accurately recognizing and expressing the degree of pain; 4. Have signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. The legal guardian refused to participate in this study; 2. Children with severe comorbidities, such as cardiac insufficiency; 3. Those with central and/or peripheral nervous system comorbidities; 4. Those who have recently taken hormone-based medications or are allergic to the study drugs; 5. Those with chronic pain or have been using opioid drugs or other painkillers for more than 3 months; 6. Those who have previously undergone spinal surgery or suffered spinal trauma; 7. Those with preoperative incision site infection; 8. Those with cognitive impairment or mental illness that prevents communication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative opioid consumption;Postoperative Numerical Rating Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative analgesia satisfaction;Postoperative Nausea and Vomiting (PONV) Assessment;Wound Healing Assessment; | — |
Countries
China
Contacts
Public ContactWang Fang
Beijing Children's Hospital, National Center for Children's Health, Capital Medical University
Outcome results
None listed